Let’s call that a earnings win!
$Cyclacel Pharmaceuticals(CYCC.US$ Cyclacel Pharmaceuticals (NASDAQ:CYCC) reported quarterly losses of $(2.27) per share which beat the analyst consensus estimate of $(4.74) by 52.11 percent. This is a 67.8 percent increase over losses of $(7.05) per share from the same period last year. The company reported $29.00 thousand in sales this quarter.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment